194 related articles for article (PubMed ID: 38294637)
1. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
Zhong S; Fu X; Wu C; Liu R; Li S
Neurosurg Rev; 2023 Nov; 46(1):311. PubMed ID: 37993665
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal disease in glioblastoma: endgame or opportunity?
Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
[TBL] [Abstract][Full Text] [Related]
9. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide for high grade glioma.
Hart MG; Garside R; Rogers G; Stein K; Grant R
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
[TBL] [Abstract][Full Text] [Related]
14. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.
Buszek SM; Chung C
Front Oncol; 2019; 9():1224. PubMed ID: 31803614
[No Abstract] [Full Text] [Related]
16. Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.
Beauchesne P; Blonski M; Brissart H
In Vivo; 2011; 25(6):991-3. PubMed ID: 22021694
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.
Andersen BM; Miranda C; Hatzoglou V; DeAngelis LM; Miller AM
Neurology; 2019 May; 92(21):e2483-e2491. PubMed ID: 31019097
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract][Full Text] [Related]
19. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Ashby LS; Smith KA; Stea B
World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
